Immediate Impact
3 from Science/Nature 90 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
Works of Mark Wiseman being referenced
Metformin in the treatment of non‐alcoholic steatohepatitis: a pilot open label trial
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mark Wiseman | 5 | 262 | 41 | 208 | 83 | 4 | 311 | |
| Gabriele Raschpichler | 249 | 86 | 178 | 74 | 5 | 353 | ||
| Barbara Fruci | 1 | 249 | 72 | 205 | 124 | 4 | 368 | |
| Souveek Mitra | 275 | 37 | 113 | 63 | 6 | 345 | ||
| Ana Ruth Araújo | 1 | 279 | 37 | 102 | 66 | 6 | 338 | |
| Margaret LP Teng | 252 | 38 | 118 | 73 | 2 | 311 | ||
| Francesca Calella | 295 | 35 | 206 | 37 | 5 | 353 | ||
| S. Genise | 1 | 284 | 32 | 207 | 37 | 4 | 349 | |
| Eliza Harting | 1 | 248 | 37 | 127 | 59 | 5 | 284 | |
| Keiichi Mori | 2 | 147 | 80 | 115 | 120 | 6 | 351 | |
| Lee-Ling Lim | 231 | 39 | 112 | 42 | 6 | 296 |
All Works
Loading papers...